In these experiments, we verified that DCI, epoxomicin, EER and siRNA targeting SPP and TAP1 had no or only a weak effect on tumour cell viability (Supplementary Figure 4d) and cell surface expression of HLA-A2 molecules (Supplementary Figure 4e). The gene discussed is HM13; the disease is neoplasm.